ng-nitroarginine methyl ester has been researched along with Hypertrophy in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (24.24) | 18.2507 |
| 2000's | 13 (39.39) | 29.6817 |
| 2010's | 9 (27.27) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Khamseekaew, J; Maneesai, P; Pakdeechote, P; Poasakate, A; Potue, P; Rattanakanokchai, S; Sangartit, W | 1 |
| Joseph, J; Kanthlal, SK; M, V; P, UD; Paul, B | 1 |
| Ikeda, T; Katsuragi, S; Kawamura, T; Maki, S; Tachibana, R; Takeuchi, H; Tanaka, H; Tanaka, K; Toriyabe, K; Yoshikawa, K | 1 |
| Coelho-Filho, OR; Das, S; Jerosch-Herold, M; Kwong, R; Mitchell, R; Moreno, H; Neilan, TG; Rosenzweig, A; Shah, RV; Simonson, B | 1 |
| Chen, R; Du, W; Huang, B; Jiang, Q; Peng, X; Qiu, H; Wu, Q; Wu, Y; Xue, L | 1 |
| Atasoy, P; Boybeyi, Ö; Soyer, T | 1 |
| Bidani, AK; Bisla, R; Griffin, KA; Licea-Vargas, H; Long, J; Picken, M; Polichnowski, AJ; Williamson, GA | 1 |
| Atsma, DE; Schalij, MJ; Umar, S; van der Laarse, A; van der Valk, EJ; van der Wall, EE | 1 |
| Champlain, Jd; Couture, R; deBlois, D; Huot-Marchand, JE; Pilon, M; Wu, R | 1 |
| Adamcova, M; Barta, A; Krajcirovicova, K; Paulis, L; Pechanova, O; Pelouch, V; Simko, F; Zicha, J | 1 |
| Belin de Chantemèle, EJ; Guihot, AL; Henrion, D; Loufrani, L; Toutain, B; Vessières, E | 1 |
| Berger, S; Duan, SZ; Frieler, RA; Ivaschenko, CY; Lumeng, CN; Mortensen, RM; Schütz, G; Usher, MG | 1 |
| Iaina, A; Levin-Iaina, N; Raz, I | 1 |
| Anderson, HD; Kardami, E; Louis, XL; Netticadan, T; Stringer, DM; Taylor, C; Thandapilly, SJ; Wigle, J; Yang, T; Yu, L; Zahradka, P; Zhang, S | 1 |
| Bailón, E; Delpón, E; Duarte, J; Galindo, P; Gómez-Guzmán, M; Jiménez, R; Lopez-Sepulveda, R; O'Valle, F; Perez-Vizcaino, F; Quintela, AM; Romero, M; Sánchez, M; Zarzuelo, MJ | 1 |
| Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H | 1 |
| Baumbach, GL; Faraci, FM; Sigmund, CD | 1 |
| Amiri, F; Iglarz, M; Neves, MF; Reudelhuber, TL; Schiffrin, EL; Seidah, NG; Touyz, RM; Virdis, A | 1 |
| Betters, JL; Criswell, DS; Lira, VA; Long, JH; Sellman, JE; Soltow, QA | 1 |
| Dumont, O; Henrion, D; Loufrani, L | 1 |
| da Cruz-Höfling, MA; da Silva, GH; Hyslop, S; Paffaro, VA; Pauli, JR; Saad, MJ; Salgado, I; Tarsitano, CA | 1 |
| Bouallegue, A; Daou, GB; Srivastava, AK | 1 |
| Bell, D; Devine, AB; McDermott, BJ; Zhao, YY | 1 |
| De Nucci, G; Fujihara, CK; Zatz, R | 1 |
| Blennerhassett, MG; Collins, SM; Hogaboam, CM; Jacobson, K | 1 |
| Beattie, EC; Gulliver, F; Morton, JJ; Speirs, A | 1 |
| Clark, DA; Eloby-Childress, S; Miller, MJ; Pierce, MR; Voelker, CA; Zhang, XJ | 1 |
| Deschepper, CF; Grove, K; Li, JS; Schiffrin, EL; Sventek, P | 1 |
| Anderson, NH; Brosnan, MJ; Clark, JS; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; McPhaden, A; Reid, JL | 1 |
| d'Uscio, LV; Lüscher, TF; Moreau, P; Takase, H | 1 |
| Chen, QH; Ding, J; Kosaka, H; Murakami, H; Nishida, Y; Wu, XZ; Zhou, MS | 1 |
| Barton, M; Boer, P; D'Uscio, LV; Gröne, HJ; Lattmann, T; Lüscher, TF; Moreau, P; Rabelink, TJ; Shaw, S; Vos, I | 1 |
| Criswell, DS; Smith, JD; Smith, LW | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Hypertrophy
| Article | Year |
|---|---|
Left ventricular hypertrophy and arterial blood pressure in experimental models of hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Susceptibility; Humans; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1997 |
32 other study(ies) available for ng-nitroarginine methyl ester and Hypertrophy
| Article | Year |
|---|---|
Kaempferol protects against cardiovascular abnormalities induced by nitric oxide deficiency in rats by suppressing the TNF-α pathway.
Topics: Animals; Antioxidants; Aorta; Blood Pressure; Cardiovascular Abnormalities; Hypertension; Hypertrophy; Kaempferols; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphatidylinositol 3-Kinases; Rats; Tumor Necrosis Factor-alpha | 2023 |
Antioxidant and vasorelaxant effects of aqueous extract of large cardamom in L-NAME induced hypertensive rats.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Antioxidants; Aorta; Arterial Pressure; Blood Vessels; Captopril; Elettaria; Hypertension; Hypertrophy; Kidney; Male; Malondialdehyde; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Vascular Remodeling; Vasodilation; Vasodilator Agents | 2020 |
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring.
Topics: Adipocytes; Animals; Diet, High-Fat; Female; Fetal Development; Fetal Growth Retardation; Glucose Tolerance Test; Hypertension; Hypertrophy; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Pregnancy; Prenatal Exposure Delayed Effects; Tadalafil | 2021 |
Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling.
Topics: Algorithms; Animals; Aortic Valve Stenosis; Biomarkers; Body Water; Cardiomyopathy, Hypertrophic; Cell Size; Contrast Media; Gadolinium DTPA; Hypertension; Hypertrophy; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Mice; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Phenotype; Random Allocation; Ventricular Remodeling | 2013 |
Curcumin attenuates cardiomyocyte hypertrophy induced by high glucose and insulin via the PPARγ/Akt/NO signaling pathway.
Topics: Anilides; Animals; Atrial Natriuretic Factor; Cells, Cultured; Chromones; Curcumin; Glucose; Hypertrophy; Insulin; Morpholines; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction | 2015 |
Selective inhibition of nitric oxide synthase causes increased muscle thickness in rat esophagus.
Topics: Animals; Enzyme Inhibitors; Esophageal Achalasia; Esophagus; Female; Hypertrophy; Injections, Intraperitoneal; Male; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peristalsis; Rats; Rats, Wistar | 2015 |
Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
Topics: Animals; Blood Pressure; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glomerular Filtration Rate; Glomerulonephritis; Hemodynamics; Hypertension; Hypertrophy; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Obesity; Proteinuria; Rats, Sprague-Dawley; Renal Circulation; Time Factors; Vascular Resistance | 2015 |
Integrin stimulation-induced hypertrophy in neonatal rat cardiomyocytes is NO-dependent.
Topics: Animals; Animals, Newborn; Calcium; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Hypertrophy; Integrins; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oligopeptides; Phenylephrine; Protein Kinase C; Rats; Signal Transduction | 2009 |
Effect of chronic inhibition of nitric oxide on hypertension, insulin resistance, and cardiovascular remodeling in glucose-fed rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Diet; Epinephrine; Glucose; Hypertension; Hypertrophy; Insulin Resistance; Male; Muscle, Smooth, Vascular; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Ventricular Remodeling | 2009 |
Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
Topics: Animals; Blood Pressure; Fibrosis; Free Radical Scavengers; Heart Ventricles; Hemodynamics; Hydroxyproline; Hypertrophy; Male; Melatonin; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Wistar | 2009 |
Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries.
Topics: Acetylcholine; Age Factors; Animals; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hypertrophy; Indomethacin; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrobenzenes; Obesity; Rats; Rats, Zucker; Regional Blood Flow; Splanchnic Circulation; Sulfonamides; Time Factors; Vascular Resistance; Vasodilation; Vasodilator Agents | 2010 |
Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.
Topics: Aldosterone; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Fibrosis; Heart; Hypertension; Hypertrophy; Interleukin-4; Macrophages; Mice; Mice, Knockout; Mice, Transgenic; Mineralocorticoid Receptor Antagonists; NG-Nitroarginine Methyl Ester; Receptors, Glucocorticoid; Receptors, Mineralocorticoid | 2010 |
The emerging role of NO and IGF-1 in early renal hypertrophy in STZ-induced diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Hypertrophy; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitrogen Oxides; Rats | 2011 |
Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway.
Topics: Adenylate Kinase; Animals; Cell Size; Hypertrophy; Male; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Niacinamide; Nitric Oxide; Norepinephrine; Protein Biosynthesis; Pyrazoles; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Resveratrol; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Stilbenes | 2011 |
Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
Topics: Animals; Atherosclerosis; Blood Pressure; Catechin; Cyclooxygenase 2; Endothelium, Vascular; Hypertension; Hypertrophy; Inflammation; Inflammation Mediators; Kidney; Male; MAP Kinase Signaling System; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Phosphorylation; Phytotherapy; Plant Extracts; Prostaglandins; Proteinuria; Rats; Rats, Wistar; Up-Regulation; Vascular Diseases; Vasoconstriction | 2011 |
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents | 2004 |
Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase.
Topics: Animals; Arterioles; Blood Pressure; Brain; Carotid Artery, Common; Edetic Acid; Endothelium, Vascular; Female; Genotype; Hypertension; Hypertrophy; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Species Specificity; Vasodilation | 2004 |
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Topics: Animals; Antioxidants; Endothelin-1; Endothelin-3; Endothelium, Vascular; Humans; Hypertrophy; Male; Mesenteric Arteries; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Receptor, Endothelin A; Receptor, Endothelin B; Receptor, TIE-2; Recombinant Fusion Proteins; RNA, Messenger; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
Ibuprofen inhibits skeletal muscle hypertrophy in rats.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Female; Florida; Humans; Hypertrophy; Ibuprofen; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2006 |
Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries.
Topics: Animals; Antihypertensive Agents; Doxycycline; Enzyme Inhibitors; Gene Expression Regulation; Hypertrophy; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mesenteric Arteries; Mice; Mice, Transgenic; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Perindopril; Rats; Rats, Wistar; Regional Blood Flow; Signal Transduction; Vascular Resistance; Vasoconstriction | 2007 |
Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Cytochrome P-450 Enzyme System; Enalapril; Enzyme Activation; Enzyme Inhibitors; Fasting; Glucose; Glycogen; Glycogen Synthase Kinase 3; Hypertension; Hypertrophy; Liver; Liver Cirrhosis; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Topics: Animals; Aorta, Thoracic; Cell Proliferation; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Focal Adhesion Kinase 2; Guanylate Cyclase; Hypertrophy; Leucine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Oxadiazoles; Phosphorylation; Protein Biosynthesis; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Receptors, Cytoplasmic and Nuclear; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Soluble Guanylyl Cyclase | 2007 |
Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
Topics: Adrenomedullin; Animals; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Endothelin-1; Gene Expression Regulation; Hypertrophy; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Neuropeptides; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Oxidative Stress; Peptides; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Protein 3; Receptor Activity-Modifying Proteins; Receptors, Cell Surface; Systole | 2008 |
Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy.
Topics: Amino Acid Oxidoreductases; Angiotensin Receptor Antagonists; Animals; Arginine; Biphenyl Compounds; Glomerulosclerosis, Focal Segmental; Hemodynamics; Hypertrophy; Imidazoles; Kidney; Kidney Glomerulus; Losartan; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Time Factors | 1995 |
The selective beneficial effects of nitric oxide inhibition in experimental colitis.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Body Weight; Colitis; Colon; Eating; Hyperplasia; Hypertrophy; Intestines; Male; Muscle, Smooth; Myenteric Plexus; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Peroxidase; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid | 1995 |
Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy.
Topics: Animals; Animals, Newborn; Arginine; Blood Pressure; Blood Vessels; Captopril; Dose-Response Relationship, Drug; Hypertension; Hypertrophy; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renin | 1993 |
Perinatal nitric oxide synthase inhibition retards neonatal growth by inducing hypertrophic pyloric stenosis in rats.
Topics: Animals; Animals, Newborn; Arginine; Body Weight; Disease Models, Animal; Embryonic and Fetal Development; Female; Growth; Guanidines; Hypertrophy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pregnancy; Pyloric Stenosis; Rats | 1995 |
Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
Topics: Animals; Aorta; Arginine; Base Sequence; Blood Pressure; Blood Vessels; Body Weight; Endothelins; Enzyme Inhibitors; Gene Expression; Heart; Hypertrophy; Molecular Sequence Data; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Organ Size; Rats; Rats, Inbred SHR; Systole | 1996 |
Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery.
Topics: Analysis of Variance; Angiotensin II; Animals; Basilar Artery; Blood Pressure; Body Weight; Enzyme Inhibitors; Hypertrophy; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Rats; Rats, Inbred WKY; Systole; Vasoconstrictor Agents; Weight Gain | 1998 |
Role of nitric oxide in vascular hyper-responsiveness to norepinephrine in hypertensive Dahl rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Hypertrophy; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Norepinephrine; Rats; Rats, Inbred Dahl; Sodium, Dietary; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |
Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis.
Topics: Acetylcholine; Animals; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Dahl; Renal Artery; Sodium Chloride, Dietary; Vasodilator Agents | 2000 |
Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload.
Topics: Adaptation, Physiological; Animals; Body Weight; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Female; Hindlimb; Hypertrophy; Muscle Fibers, Skeletal; Muscle, Skeletal; Myosin Heavy Chains; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protein Isoforms; Rats; Rats, Sprague-Dawley | 2002 |